Lipid Metabolism and Cardiometabolic Diseases: Latest Advances and Prospects
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Lipid Metabolism".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 1713
Special Issue Editors
Interests: cardiometabolic disease; lipid metabolism; cardio-vascular disease; metabolic disease
Interests: cardiometabolic risk; cardiometabolic disease; biomarkers; endothelial function; sphingolipids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lipids play a key role in several process associated with physiological conditions, such as cell function, metabolism, and distribution. Changes in lipid components can have profound effects on cell function, the immune system, antioxidant defenses, and inflammatory responses. Lipid metabolites are indispensable regulators of physiological and pathological processes, including atherosclerosis, endothelial dysfunction and coronary artery disease (CAD). The determination of individual lipid characteristics (composition and abundance) via new tools and information technologies in biosamples could be a powerful tool able to facilitate an understanding of the mechanisms implicated in lipid-based diseases. The mechanisms that are related to lipids and particular species (i.e., ceramides, phosphocholine, lysophosphatidylcholines) and the development of CAD remain poorly understood. We invite investigators to contribute either original research or review articles that are in accordance with this Special Issue, which focuses on the interplay among lipid dysregulation-related diseases, including diabetes, obesity, metabolic-associated fatty liver disease (MAFLD), atherosclerosis, hypertension, and CAD. Subtopics that are also of interest include, but are not limited to, the following:
- Lipid assessment and cardiometabolic syndrome;
- Metabolomic/lipidomic approach and cardiometabolic risk;
- Glucose metabolism and diabetes associated with cardiometabolic disease;
- Insulin resistance and atherosclerosis, endothelial dysfunction and coronary artery disease;
- Lipidomic techniques for the discovery of new biomarkers and diagnostic/prognostic tools for cardiometabolic disease.
Dr. Melania Gaggini
Dr. Cristina Vassalle
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lipidomic
- lipotoxicity
- oxidative stress
- obesity
- dyslipidemia
- cardiovascular risk
- diabetes
- insulin resistance
- fatty liver